The Real Dangers Of Lower Blood Pressure Medications American Chronicle, CA - Nov 22, 2008 The following are just a few of the more common types of medication and the problems they can cause: Beta-blockers, one of the oldest and most common ...
Class: Short acting bronchodilator (selective beta-2 agonist) EMS1.com - Emergency Medical Service Resources, CA - Nov 18, 2008 In overdose anticipated symptoms would reflect excessive beta adrenergic stimulation. Judicious use of a cardioselective beta adrenergic blocker may be ...
Balance Risk Of Childhood Obesity Medications Tampa Tribune, FL - Nov 12, 2008 Beta blockers and diuretics for a kid? That seems absurd. Ian Paul, an associate professor of pediatrics at Penn State University Children's Hospital, ...
Erectile dysfunction and heart disease 2: At-risk patients Nursing Times, UK - Nov 25, 2008 In the same way, men who take beta-blockers and diuretics, among other drugs, should be advised about the possibility of drug-induced ED and asked to report ...
Head banging Melbourne Herald Sun, Australia - Nov 15, 2008 Medication includes beta-blockers, which are normally used for high blood pressure; amitriptyline, an anti-depressant; and anti-convulsants normally ...
Bags of drugs lost in Pembroke Western Telegraph, UK - Nov 4, 2008 In a separate incident a patient has lost a box of Antenolol beta blocker tablets in Merlin's Cross. The box contains 16 or 17 tablets and each tablet is 50 ...
Genetic Factors Behind Schizophrenia Identified Oneindia, India - German researchers have identified genetic variations whose presence may increase a person's risk of becoming schizophrenic. "We were able to identify three ...
Truce Time in the Fan-Fred Wars Wall Street Journal - Prior to the mortgage meltdown, critics pointed to those portfolios as the source of systemic risk. They argued that Fannie and Freddie should stick to ...
Parents and pot Chicago Daily Herald, IL - Aug 3, 2008 Quite a bit of data shows that in many instances, kids who start to smoke pot are at greater risk of developing depression or anxiety as they grow up, ...
Opportunity Knocks as Paterson Tackles Budget New York Times, United States - Aug 2, 2008 He warned that the situation could become as bad as in the Great Depression, and invoked the name Herbert Hoover in telling the State Legislature and ...
Exercise Doesn't Improve Mood MedPage Today, NJ - 4 -- Regular exercise does not reduce anxiety and depression in the general population, researchers here found. Explain to interested patients that prior ...
Behavioral Comorbidities in Rheumatoid Arthritis Psychiatric Times, NY - 3,4 The combined burden of stress, pain, and depression increase vulnerability to illness and reduce capacity for successful adaptation. ...
Many Oklahoma Women Suffer From Depression After Childbirth eMaxHealth.com, NC - Aug 2, 2008 Among the stressors found to increase the risk of depression symptoms are arguing with a partner more than usual during pregnancy, having bills one cannot ...
Does growing old increase the risk for depression? - RE Roberts, GA Kaplan, SJ Shema, WJ Strawbridge - Am J Psychiatry, 1997 - ncbi.nlm.nih.gov 1997 Oct;154(10):1384-90. Click here to read Does growing old increase the risk
for depression? Roberts RE, Kaplan GA, Shema SJ, Strawbridge WJ. ...
[CITATION] Increasing rates of depression - GL Klerman, MM Weissman - JAMA: The Journal of the American Medical Association, 1989 - JAMA ... compared with controls; and the suggestion of a narrowing of the differential risk
to men and women due to a greater increase in risk of depression among young ...
Last Updated: 2006-12-06 12:15:23 -0400 (Reuters Health)
By Will Boggs, MD
NEW YORK (Reuters Health) - Treatment with a class of drugs called beta-blockers do not appear to increase a patient's risk of depression in the first year after a heart attack, according to a report in the Journal of the American College of Cardiology.
Physicians do not have to be hesitate in prescribing beta-blockers in heart attack patients anymore, Dr. Joost P. van Melle from University Medical Center Groningen, the Netherlands, told Reuters Health. Some common beta-blocker trade names used in the U.S. include Inderal, Lopressor and Toprol XL.van Meller and his colleagues note that beta-blockers have reduced mortality in heart patients by 23 percent. These drugs are also used to treat high blood pressure, angina, migraine and other disorders. However, concerns about neurological, psychological and other side effects persist.
The researchers investigated the association between beta-blocker use and depression in the first 12 months after heart attack 381 patients.
Article continues below and (thank you)
The team found that Beck Depression Inventory Scores at 3, 6, and 12 months post-heart attack did not differ significantly in patients taking beta-blockers and patients not taking beta-blockers. The results indicate that patients taking beta-blockers were no more likely to be diagnosed with depressive disorder during the year after their heart attack than those not taking beta-blockers.
Among patients taking beta-blockers, outcomes did not differ by type of beta-blocker they received -- a hydrophilic beta-blocker or a lipophilic beta-blocker.
"Despite current beliefs about the potential side effects of beta-blockade," van Melle and colleagues write, "we found no support for short-term effects on prospective depression in an (heart attack) population."
However, at 6 and 12 months, the researchers note, patients taking high-dose beta-blockers had significantly higher scores on the Beck Depression Inventory test (indicating lower depression levels) than did patients taking low-dose beta-blockers.
"More research is warranted to explore the long-term and high-dose effects of beta-blockers on depressive (symptoms)," the investigators conclude.
SOURCE: Journal of the American College of Cardiology, December 5, 2006.
Last Updated: 2006-12-06 16:37:25 -0400 (Reuters Health)
NEW YORK (Reuters Health) - Vaccination with an antibody designated 105AD7 induces an immune response in colon cancer patients. This effect could be useful in combating the cancer, according to a report in Clinical Cancer Research.
Earlier trials of 105AD7 in patients with advanced colon cancer showed it to be nontoxic, the authors explain, but treatment failed to provide a significant survival benefit.
Dr. Lindy G. Durrant and colleagues from University Hospital Nottingham, UK, investigated the use of 105AD7 as an added therapy in 67 colon cancer patients undergoing surgery.
The vaccine was effective in inducing an immune response in the patients. Moreover, there was some preliminary evidence that it might improve survival.
The researchers call for further studies to clarify the effects of the vaccine.
SOURCE: Clinical Cancer Research, November 22, 2006.
